Attorneys and journalists: Newsroom Tools Search
perfectplaintiff Find an attorney
  1. Home
  2. Mass torts
  3. Genentech, Inc., Herceptin (Trastuzumab) Marketing and Sales Practices Litigation

Genentech, Inc., Herceptin (Trastuzumab) Marketing and Sales Practices Litigation

MDL No. 2700 · Sales Practices · U.S. District Court, Northern District of Oklahoma

What are these lawsuits about?

These actions share factual questions arising from Genentech’s marketing and sales of Herceptin (trastuzumab), a prescription medication for the treatment of certain types of breast cancer. Plaintiffs in all the actions are oncology providers who allege that Genentech breached its warranties regarding the amount, volume, or concentration of Herceptin that it sold them.

Judicial Panel on Multidistrict Litigation, transfer order of 7 April 2016 in MDL No. 2700 Sourced

This is the Panel's own description, quoted word for word from the order that created the litigation. It describes what the lawsuits allege, not what has been proved, and the litigation may have changed since.

The basics

Name on the docketIN RE: Genentech, Inc., Herceptin (Trastuzumab) Marketing and Sales Practices Litigation
Multidistrict litigation numberMDL No. 2700
CourtU.S. District Court, Northern District of Oklahoma
JudgeGregory K. Frizzell (Chief Judge, USDC)
Master docket number4:16-md-2700
Court filingsFiled under the master docket number above. How to look up the filings
CategorySales Practices
Filed with the Panel5 February 2016
Sent to this court7 April 2016
StatusPending on the Panel's report of 2 November 2026

These details are as the Judicial Panel on Multidistrict Litigation lists them.

How fast have lawsuits been filed?

A year-by-year count is not available for this litigation. We show one only when the federal case database's total for the docket is close to the Panel's, and here it is not, or the litigation is too new.

Common questions

How many lawsuits are pending in the Genentech, Inc., Herceptin (Trastuzumab) Marketing and Sales Practices Litigation?

12 lawsuits were pending as of 2 November 2026, out of 15 filed or transferred into the litigation since it began, according to the Judicial Panel on Multidistrict Litigation (sourced).

What is the Genentech, Inc., Herceptin (Trastuzumab) Marketing and Sales Practices Litigation about?

In the order that created the litigation, the Judicial Panel on Multidistrict Litigation described it this way: "These actions share factual questions arising from Genentech’s marketing and sales of Herceptin (trastuzumab), a prescription medication for the treatment of certain types of breast cancer. Plaintiffs in all the actions are oncology providers who allege that Genentech breached its warranties regarding the amount, volume, or concentration of Herceptin that it sold them." That describes what the lawsuits allege, not what has been proved.

Which court and judge are handling the Genentech, Inc., Herceptin (Trastuzumab) Marketing and Sales Practices Litigation?

It is MDL No. 2700, before Gregory K. Frizzell (Chief Judge, USDC) in the U.S. District Court, Northern District of Oklahoma. The master docket number is 4:16-md-2700.

Is the Genentech, Inc., Herceptin (Trastuzumab) Marketing and Sales Practices Litigation a class action?

It is a multidistrict litigation, which is different from a class action. Each lawsuit in a multidistrict litigation stays a separate case with its own outcome; the cases are gathered before one judge for pretrial work. A multidistrict litigation can include class actions among its cases.

Has the Genentech, Inc., Herceptin (Trastuzumab) Marketing and Sales Practices Litigation settled?

We found no settlement amount for this litigation in company filings with the Securities and Exchange Commission. That does not mean none exists: private companies and most foreign companies do not file such reports, and many settlements are confidential. The litigation was still on the Panel's list of pending litigations on 2 November 2026, which means it had not been closed.

Has a settlement amount been disclosed?

We found no settlement amount for this litigation in company filings with the Securities and Exchange Commission. That does not mean none exists: private companies and most foreign companies do not file such reports, and many settlements are confidential. We do not estimate settlement amounts. Amounts that have been disclosed for other litigations are in the settlement tracker.

How has the number of pending lawsuits moved?

On 3 November 2025, 13 lawsuits were pending. On 2 November 2026, 12 were (sourced from the Panel's monthly reports).

Report dateLawsuits pending
3 November 202513
2 December 202513
5 January 202613
2 February 202613
2 March 202613
1 April 202613
1 May 202613
1 June 202613
1 July 202613
3 August 202613
1 September 202612
1 October 202612
2 November 202612

A month is missing where we could not read every row of that month's report. Every litigation is compared in the mass tort tracker.

How long do litigations like this last?

We do not estimate when this litigation will end; we make no estimates about any named litigation. For a sense of scale, this is how long finished litigations lasted, from the first case filed to the last case closed, grouped by how many cases they held.

How long finished litigations lastedComputed

Size of litigationFinished litigations measuredMedian lengthMiddle half lasted
100 to 999 cases438 years5.5 to 9.5 years
1,000 to 9,999 cases1011 years9.5 to 12.5 years
10,000 cases or moreToo few to compare——

A litigation counts as finished when no case carrying its docket number is still pending. A group is shown only when at least ten finished litigations can be measured.

Related litigations

Other sales practices litigations

All pending litigations

Sources

Last updated 18 November 2026. That is the date we last retrieved the source files below.

Download the figures behind this page (CSV). Every row gives its label and its source. More files are in the data catalogue.

  • U.S. Judicial Panel on Multidistrict Litigation, MDL Statistics Report: pending MDL dockets File retrieved 18 November 2026 from jpml.uscourts.gov. File fingerprint 2854e718c8e5.
  • U.S. Judicial Panel on Multidistrict Litigation, MDL Statistics Report: pending MDL dockets File retrieved 16 November 2026 from jpml.uscourts.gov. File fingerprint 4c8c598b9758.
  • U.S. Judicial Panel on Multidistrict Litigation, MDL Statistics Report: pending MDL dockets File retrieved 16 November 2026 from jpml.uscourts.gov. File fingerprint 02acf48f3753.
  • U.S. Judicial Panel on Multidistrict Litigation, MDL Statistics Report: pending MDL dockets File retrieved 16 November 2026 from jpml.uscourts.gov. File fingerprint 06530a1c2eba.
  • U.S. Judicial Panel on Multidistrict Litigation, MDL Statistics Report: pending MDL dockets File retrieved 16 November 2026 from jpml.uscourts.gov. File fingerprint f9835afbad7a.
  • U.S. Judicial Panel on Multidistrict Litigation, MDL Statistics Report: pending MDL dockets File retrieved 16 November 2026 from jpml.uscourts.gov. File fingerprint beecdb1fcbd3.
  • U.S. Judicial Panel on Multidistrict Litigation, MDL Statistics Report: pending MDL dockets File retrieved 16 November 2026 from jpml.uscourts.gov. File fingerprint 68ffe884f3c4.
  • U.S. Judicial Panel on Multidistrict Litigation, MDL Statistics Report: pending MDL dockets File retrieved 16 November 2026 from jpml.uscourts.gov. File fingerprint 8d89078404ff.
  • U.S. Judicial Panel on Multidistrict Litigation, MDL Statistics Report: pending MDL dockets File retrieved 16 November 2026 from jpml.uscourts.gov. File fingerprint 6bdcea2af28e.
  • U.S. Judicial Panel on Multidistrict Litigation, MDL Statistics Report: pending MDL dockets File retrieved 16 November 2026 from jpml.uscourts.gov. File fingerprint 1aa2181acd5a.
  • U.S. Judicial Panel on Multidistrict Litigation, MDL Statistics Report: pending MDL dockets File retrieved 16 November 2026 from jpml.uscourts.gov. File fingerprint 1c5e7f62c95a.
  • U.S. Judicial Panel on Multidistrict Litigation, MDL Statistics Report: pending MDL dockets File retrieved 16 November 2026 from jpml.uscourts.gov. File fingerprint 1113fa70c312.
  • U.S. Judicial Panel on Multidistrict Litigation, MDL Statistics Report: pending MDL dockets File retrieved 16 November 2026 from jpml.uscourts.gov. File fingerprint 9e1e4117add7.
  • Federal Judicial Center Integrated Database (civil, 1988 forward) File retrieved 18 November 2026 from fjc.gov. File fingerprint 74405231a9a3.
Where each sourced figure appears in the source (2)
  • Actions pending, Multidistrict litigation (all types): Distribution of Pending MDL Dockets by Actions Pending, row 'MDL -2700', column 'Actions Now Pending'. As published: 12
  • Total actions to date, Multidistrict litigation (all types): Distribution of Pending MDL Dockets by Actions Pending, row 'MDL -2700', column 'Total Actions (Historical)'. As published: 15

The full address of every source file is on the sources page. Found something wrong? See corrections and removal requests. How figures are labelled and calculated is in the methodology.